Considering our above-described data demonstrating that knockout of A2B1 evidently suppressed the tumorigenesis and progression of HCC in vivo (Fig. 4), we further validate whether the function of A2B1 on the tumorigenesis and progression of HCC in vivo is dependent on the low expression of PCK1. The gene discussed is PCK1; the disease is hepatocellular carcinoma.